2023 Transferred values declared to VVKT

Transferred values

2023 Disclosing Reports for transfered values

AbbVie, UAB

2024-07-01

AstraZeneca Lietuva, UAB

2024-07-01

Bayer, UAB

2024-07-01

Biogen Lithuania, UAB

2024-07-01

Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas

2024-07-01

Egis Pharmaceuticals PLC atstovybė Lietuvoje

2024-07-01

Eli Lilly Lietuva, UAB

2024-07-01

Ipsen Pharma SAS Lietuvos filialas

2024-07-01

Johnson & Johnson, UAB

2024-09-09

Medochemie, UAB

2024-07-01

Merck Serono, UAB

2024-07-01

Merck Sharp & Dohme, UAB

2024-07-01

Mylan Healthcare, UAB

2024-07-01

Novo Nordisk Pharma, UAB

2024-07-01

Pfizer Luxembourg SARL filialas

2024-07-01

Servier Pharma, UAB

2024-07-01

SIA Novartis Baltics Lietuvos filialas

2024-07-01

Takeda, UAB

2024-07-01

Teva Baltics, UAB

2024-07-01

Companies that had no transferred values during year 2023

Berlin Chemie Menarini Baltic, UAB

Gedeon Richter Plc. atstovybė Lietuvoje

Zentiva Group, a.s. Lietuvos filialas

Disclosure reports of 2022 transfers of value

Disclosure reports of 2021 transfers of value

Disclosure reports of 2020 transfers of value

Disclosure reports of 2019 transfers of value

Disclosure reports of 2018 transfers of value

Disclosure reports of 2017 transfers of value

Disclosure reports of 2016 transfers of value

Disclosure reports of 2015 transfers of value